Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05249634 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Testosterone Treatment in Men With Chronic Kidney Disease

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study Identification, Study Statusv6
  2. Primary completion date: Jun 30, 2026 to Jun 2028
    • Study completion date: Dec 31, 2026 to Dec 2028
    v5
  3. Primary completion date: Jun 30, 2024 to Jun 30, 2026
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v4
  4. Primary completion date: Jun 30, 2023 to Jun 30, 2024
    • Study completion date: Dec 31, 2023 to Dec 31, 2024
    v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
Trial Details
NCT Number NCT05249634
Lead Sponsor St. Louis University
Collaborators: Clarus Therapeutics, Inc.
Conditions
(from sponsor)		 Hypogonadism, Male, Kidney Disease, Chronic
Related terms Eunuchism, Renal Insufficiency, Chronic
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov